These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21129498)

  • 21. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology.
    van der Greef J; McBurney RN
    Nat Rev Drug Discov; 2005 Dec; 4(12):961-7. PubMed ID: 16341061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Collaboration with universities and innovate activity in the Spanish pharmaceutical industry (2003-2005)].
    D'Este P; Tribó JA; García-Romero A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():66-70. PubMed ID: 19631826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DPI delivers biotechnology superstore. Discovery Partners International.
    Glaser V
    Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Science for sale: academic meets industry.
    Bernstein R
    Cell; 2012 Jul; 150(2):239-40. PubMed ID: 22817884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collaborations among academia, government, and industry in the diagnostics space: barriers and some ideas for solutions.
    Evans G; Austin F
    Sci Transl Med; 2010 Dec; 2(63):63mr3. PubMed ID: 21178133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a compliant approach to industry support for research and education in a climate of scrutiny.
    Kannensohn KJ; Soldato D; Carnell H
    Health Care Law Mon; 2010 Feb; 2010(2):2-7. PubMed ID: 20175336
    [No Abstract]   [Full Text] [Related]  

  • 31. The nature of outsourced preclinical research--the example of chemical synthesis.
    Festel GW
    Expert Opin Drug Discov; 2013 Sep; 8(9):1049-55. PubMed ID: 23725522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Productivity shortfalls in drug discovery: contributions from the preclinical sciences?
    Williams M
    J Pharmacol Exp Ther; 2011 Jan; 336(1):3-8. PubMed ID: 20739456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakthrough ideas for 2010.Getting the drugs we need.
    Bonabeau E; Bingham A; Schacht A
    Harv Bus Rev; 2010; 88(1):48, 50. PubMed ID: 20088372
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug discovery alliances in India--indications, targets, and new chemical entities.
    Differding E
    ChemMedChem; 2014 Jan; 9(1):43-60. PubMed ID: 24136820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creating effective medicinal chemistry collaborations in drug discovery.
    Giardina GA; Raveglia LF
    Future Med Chem; 2009 Apr; 1(1):3-6. PubMed ID: 21426065
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug discovery.
    Kennedy D
    Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
    [No Abstract]   [Full Text] [Related]  

  • 37. Accelerating technology transfer: new relationships for academia, industry and government.
    Satava RM
    Stud Health Technol Inform; 1998; 50():1-6. PubMed ID: 10180523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Where do innovative drugs come from?
    Higgs G
    Drug Discov Today; 2011 Nov; 16(21-22):907-9. PubMed ID: 21889605
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets.
    Hardy LW; Peet NP
    Drug Discov Today; 2004 Feb; 9(3):117-26. PubMed ID: 14960389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.